Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Accentus
- Development stage
- Unknown
- Lead developer
- Peak Health
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Accentus is a dietary supplement developed and marketed by Peak Health Foundation (Peak Health). It is part of a line of Ayurvedic-inspired wellness products designed for cardiovascular support and general health maintenance. As a consumer-grade nutraceutical, Accentus is not a regulated pharmaceutical drug and does not have a formal clinical development pipeline, molecular target data, or FDA-approved therapeutic indications. The product is typically administered orally and is intended to support heart health through a blend of botanical ingredients. It is sold directly to consumers alongside other wellness products such as Athero and Kriya Hops.
- Brand names
- Accentus
Beyond the preview
Go deeper on Accentus.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Accentus.